0.2246
price up icon5.45%   0.0116
after-market 시간 외 거래: .23 0.0054 +2.40%
loading
전일 마감가:
$0.213
열려 있는:
$0.2178
하루 거래량:
3.31M
Relative Volume:
0.20
시가총액:
$2.67M
수익:
-
순이익/손실:
$-11.53M
주가수익비율:
-0.0466
EPS:
-4.82
순현금흐름:
$-11.12M
1주 성능:
+4.81%
1개월 성능:
-29.83%
6개월 성능:
-69.11%
1년 성능:
-86.22%
1일 변동 폭
Value
$0.2071
$0.225
1주일 범위
Value
$0.20
$0.225
52주 변동 폭
Value
$0.15
$3.10

프로세사 파마슈티컬스 Stock (PCSA) Company Profile

Name
명칭
Processa Pharmaceuticals Inc
Name
전화
443-776-3133
Name
주소
7380 COCA COLA DRIVE, HANOVER
Name
직원
13
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
PCSA's Discussions on Twitter

PCSA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.2246 5.61M 0 -11.53M -11.12M -4.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

프로세사 파마슈티컬스 Stock (PCSA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-04-25 개시 H.C. Wainwright Buy

프로세사 파마슈티컬스 주식(PCSA)의 최신 뉴스

pulisher
06:04 AM

What drives Processa Pharmaceuticals Inc. stock priceRapid wealth accumulation - Autocar Professional

06:04 AM
pulisher
Jul 20, 2025

What analysts say about Processa Pharmaceuticals Inc. stockRapid growth trajectories - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Processa Pharmaceuticals Inc. Stock Analysis and ForecastRapid profit acceleration - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is Processa Pharmaceuticals Inc. a good long term investmentRecord-breaking gains - Autocar Professional

Jul 19, 2025
pulisher
Jul 18, 2025

RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Des Moines Register

Jul 18, 2025
pulisher
Jul 18, 2025

Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest

Jul 18, 2025
pulisher
Jul 16, 2025

How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Best Performing Stock Suggestions - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN

Jul 13, 2025
pulisher
Jul 11, 2025

Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Processa Stock Soars 33.96% on Penny Stock Inclusion - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Processa Stock Soars 14.62% on Penny Stock Inclusion - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

12 Best Fundamentally Strong Penny Stocks to Invest in - Insider Monkey

Jul 08, 2025
pulisher
Jul 03, 2025

HC Wainwright Has Positive Estimate for Heatwurx Q2 Earnings - Defense World

Jul 03, 2025
pulisher
Jul 02, 2025

Processa terminates license agreement for PCS3117 - TipRanks

Jul 02, 2025
pulisher
Jul 01, 2025

Processa Pharmaceuticals adjourns annual meeting due to lack of quorum By Investing.com - Investing.com UK

Jul 01, 2025
pulisher
Jun 30, 2025

Processa Pharmaceuticals adjourns annual meeting due to lack of quorum - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Processa Pharmaceuticals Adjourns Annual Shareholder Meeting - TipRanks

Jun 30, 2025
pulisher
Jun 23, 2025

Processa Pharmaceuticals Plunges 15.31% Amid Market Volatility - AInvest

Jun 23, 2025
pulisher
Jun 20, 2025

Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media

Jun 20, 2025
pulisher
Jun 18, 2025

Processa Pharmaceuticals Announces Public Offering Pricing - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Processa inks licensing deal with Intact for gastroparesis drug By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - The Manila Times

Jun 18, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals (PCSA) Sets Public Offering Price at $0 - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals Signs Binding Term Sheet Granting - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals (PCSA) Enters Licensing Agreement for G - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals Prices of $7 Million Public Offering - citybiz

Jun 17, 2025
pulisher
Jun 17, 2025

Processa inks licensing deal with Intact for gastroparesis drug - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering | PCSA Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals (PCSA) Announces Public Offering Pricin - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals Prices $7 Million Public Offering - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pares Gains on Equity Offer News - MarketWatch

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals (PCSA) Announces Public Offering Pricing | PCSA Stock News - GuruFocus

Jun 17, 2025

프로세사 파마슈티컬스 (PCSA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):